Document is current
Any future updates will be listed below
-
Authors
Laugesen, Ina Grønkjaer
Mygind, Anna
Grove, Erik Lerkevang
Bro, Flemming
-
Funding
Funding for this research was provided by:
General Practice Research Foundation of the Central Denmark Region (file no. 1-30-72-112-16)
Foundation for General Practice (file no. A4105)
- License Information
-
More Information
Article History
Received: 29 January 2025
Accepted: 23 April 2025
First Online: 15 May 2025
Declarations
:
: The study was conducted in accordance with the general ethical principles of good clinical research practice as outlined by the World Medical Association in the Declaration of Helsinki. The Central Denmark Region authorised the use of data from electronic patient records in general practice under Sect. 46(2) of the Danish Health Act, thereby waiving the requirement for written patient consent (file no.: 1-45-70-29-22). Before data collection, a data processing agreement was signed with each included general practice clinic.
: The authors declare no competing interests related to this manuscript. ELG has previously received speaker honoraria or consultancy fees from AstraZeneca, Bayer, Bristol-Myers Squibb, Pfizer, Novo Nordisk, Lundbeck Pharma and Organon. He is engaged in clinical studies sponsored by AstraZeneca, Idorsia or Bayer and has received unrestricted research grants from Boehringer Ingelheim.
